Karisa C. Schreck

United States Food and Drug Administration

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers”.

Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002473

N/A

2.5DataRank · unranked

67 citations

Karisa C. Schreck, Wei Fu, Chen Hu, Alexander Carvajal-González, Roisín M. Connolly +18 more

CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas

Magnetic Resonance Imaging(2023)10.1016/j.mri.2023.06.003

N/A

0.500DataRank · unranked

10 citations

Jingpu Wu, Nhat Le, Yiqing Shen, Pengfei Guo, Karisa C. Schreck +16 more

A brave new framework for glioma drug development

The Lancet Oncology(2024)10.1016/s1470-2045(24)00190-6

N/A

0.494DataRank · unranked

26 citations

Philipp Karschnia, Karisa C. Schreck, Marjolein Geurts, Timothy F. Cloughesy, Jason T. Huse +34 more

Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101148

N/A

0.442DataRank · unranked

18 citations

Samuel M. Curtis, Mahmoud Summers, Tej D. Azad, Jordina Rincón-Torroella, Yuxuan Wang +35 more

Poly (ADP-ribose) Polymerase Inhibitor Resistance Driven by Emergence of Polyclonal Mutations With Convergent Evolution: A Molecular Tumor Board Discussion

JCO Precision Oncology(2024)10.1200/po.24.00254

N/A

0.284DataRank · unranked

5 citations

Jaime Wehr, Katerina Karaindrou, Rena R. Xian, Christopher D. Gocke, Ming‐Tseh Lin +35 more

Detection of Human Brain Cancers using Genomic and Immune Cell Characterization of Cerebrospinal Fluid through CSF-BAM

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1788

N/A

0.257DataRank · unranked

4 citations

Yuxuan Wang, Anita Kalluri, Megan Parker, Joshua D. Cohen, Jonathan C. Dudley +37 more

State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond

American Society of Clinical Oncology Educational Book(2024)10.1200/edbk_431450

N/A

0DataRank · unranked

19 citations

Μαρία Ιωάννου, Marjolein Geurts, Martin J. van den Bent, Ingo K. Mellinghoff, Karisa C. Schreck +1 more

Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3241

N/A

0DataRank · unranked

20 citations

Roy E. Strowd, Burt Nabors, Benjamin M. Ellingson, Michael Chang, Sze Kiat Tan +13 more

NF1 expression profiling in IDH-wildtype glioblastoma: genomic associations and survival outcomes

Acta Neuropathologica Communications(2024)10.1186/s40478-024-01875-z

N/A

0DataRank · unranked

9 citations

Mohamed Sherief, Maria Ioannou, Viveka Chinnasamy, Lucy Chen, Michael Frost +13 more

Druggable genomic landscapes of high-grade gliomas

Frontiers in Medicine(2023)10.3389/fmed.2023.1254955

N/A

0DataRank · unranked

14 citations

Maria Fatteh, David Kamson, Archana Balan, Michael Chang, Jessica J. Tao +8 more

Subgroup and subtype-specific outcomes in adult medulloblastoma

Acta Neuropathologica(2021)10.1007/s00401-021-02358-4

N/A

0DataRank · unranked

79 citations

Lakshmikirupa Sundaresan, Kyle Smith, Patryk Skowron, Luca Massimi, Charles G. Eberhart +44 more

Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAFV600E-Mutant Human Glioma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2660

N/A

0DataRank · unranked

40 citations

Andrew Morin, Guisheng Zhao, Amy N. Allen, Patrick Flannery, Michael Glantz +13 more

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma

Oncogene(2022)10.1038/s41388-022-02305-x

N/A

0DataRank · unranked

41 citations

Marielle E. Yohe, Kai Pollard, Angelina V. Vaseva, Ana Calizo, Lindy Zhang +10 more

Seq-ing the SINEs of Central Nervous System Tumors in Cerebrospinal Fluid DNA

medRxiv(2022)10.1101/2022.06.28.22276835

N/A

0DataRank · unranked

0 citations

Samuel M. Curtis, Mahmoud Summers, Tej D. Azad, Jordina Rincón-Torroella, Bracha Erlanger Avigdor +33 more

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

Neuro-Oncology(2020)10.1093/neuonc/noaa015

N/A

0DataRank · unranked

41 citations

Michael Weller, Joohee Sul, Stephen Bagley, Solmaz Sahebjam, Martin J. van den Bent +19 more